Abstract:Background The presence of microvascular invasion (MVI) reduces overall survival of hepatocellular carcinoma (HCC). Recent studies showed DNA methylation markers could be applied to the diagnosis of cancers. However, it is unclear whether DNA methylation signatures could help diagnose MVI in HCC. Methods To identify DNA methylation markers for HCC and MVI diagnosis, we first generated genome-wide DNA methylation profiles from HCC tissues and adjacent normal liver tissues of 37 HCC patients (20 MVI+ and 17 MVI-). We also investigated DNA methylation profiles of plasma samples from these 37 HCC patients and 30 normal individuals as controls to minimize the interference of random background DNA methylation signals. Tissue and plasma samples were prepared into DNA methylation library and sequenced on Illumina Hiseq X10 platform. Using methylation haplotype load (MHL) and unmethylation haplotype load (UMHL) as metrics, we quantified DNA methylation profiles on methylation haplotype blocks (MHBs) by computing the degree of linkage between methylated or unmethylated CpGs in HCC and adjacent normal samples to identify discriminatory markers. Grouping samples from our cohort into training and validation sets respectively, we employed two supervised machine learning algorithms, random forest (RF) and support vector machine (SVM) to train and cross-validate binary predictive models. Results Supervised analyses identified 65 MHBs as classifiers for HCC tissues and adjacent normal liver tissues. Both RF- and SVM-built models were highly accurate in classifying HCC and normal liver tissues with AUC no less than 0.98 (AUC: 98%, CI: 97.3%∼98.8% for RF model; AUC: 99.9%, CI: 99.9 ∼ 99.9% for SVM model). We applied the RF-trained classification model to differentiate HCC plasma DNA from those of healthy controls, with AUC of 96% (CI: 95.1% - 96.9%). We further identified 6 MHL-quantified MHBs and 5 UMHL-quantified MHBs as classifiers for MVI- and MVI+ samples. Combining the MHBs’ methylation scores as classifiers and applying RF method, we trained and cross-validated MVI- and MVI+ classification models. We found the AUC of these models is 85.9% (CI: 83.5% - 88.3%). Conclusions These data showed that DNA methylation signatures can provide outstanding diagnostic accuracy for HCC and MVI.

Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA

Tumor detection by analysis of both symmetric- and hemi-methylation of plasma cell-free DNA

Identification of methylation and hydroxymethylation haplotype blocks as distal regulatory elements aids in deconvolution of heterogeneous brain tissues

Wemics: A Single‐Base Resolution Methylation Quantification Method for Enhanced Prediction of Epigenetic Regulation

The Identification of Specific Methylation Patterns across Different Cancers

MethHaplo: combining allele-specific DNA methylation and SNPs for haplotype region identification

A DNA Methylation Haplotype Block Landscape in Human Tissues and Preimplantation Embryos Reveals Regulatory Elements Defined by Comethylation Patterns.

Discriminating Origin Tissues of Tumor Cell Lines by Methylation Signatures and Dys-Methylated Rules

Functional DNA methylation differences between tissues, cell types, and across individuals discovered using the M&M algorithm

Circulating Methylated DNA As Biomarkers for Cancer Detection

A Novel Method of Microarray Quantitave Analysis of P16 CPG Island Methylation in Leukemia Cells from Patients with Hematological Malignancies.

Aberrant methylation scanning by quantitative DNA melting analysis with hybridization probes as exemplified by liquid biopsy of SEPT9 and HIST1H4F in colorectal cancer

Characterization of Cell Free Plasma Methyl-DNA From Xenografted Tumors to Guide the Selection of Diagnostic Markers for Early-Stage Cancers

DNA methylation linkage disequilibrium block are associated with cancer

DNA Methylation Markers for Diagnosis and Prognosis of Common Cancers.

Evaluating methylation of human ribosomal DNA at each CpG site reveals its utility for cancer detection using cell-free DNA

Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes

IDDF2019-ABS-0302 Identification of DNA Methylation Signatures for Microvascular Invasion in Hepatocellular Carcinoma

Absolute quantification of DNA methylation using microfluidic chip-based digital PCR

Identification of 5mC within heterogenous tissue using de-novo somatic mutations

A Computational Framework To Simultaneously Quantify Dna Methylation, Somatic Copy Number Alternation And Dna Heterogeneity From Low Coverage Plasma Circulating Dna Sequencing